SCLEROTHERAPY FOR ORAL HEMANGIOMAS: EFFICACY AND SAFETY EVALUATION
Main Article Content
Keywords
Oral hemangioma, sclerotherapy, lesion regression, safety, efficacy, oral vascular tumor.
Abstract
Background: Oral hemangiomas are harmless vascular tumors that may lead to functional deficiency, hemorrhage, and cosmetic issues. Minimally invasive treatment has been realized through sclerotherapy.
Objective: To identify the efficacy and safety of sclerotherapy as an oral hemangioma treatment method, lesion regression, functional outcome, and complication rates related to treatment.
Methods: It was a proposed intervention study that was executed in Abbasi Shaheed Hospital, Karachi, Pakistan, from Feb 2024 to July 2024. Intralesional sclerotherapy using 3 percent sodium tetradecyl sulfate was used to treat 40 patients with clinically and radiographically confirmed oral hemangiomas. The lesion size, the positive effects of the treatment currently used with respect to symptoms, and the adverse effects at 1, 3, and 6 months of treatment were determined.
Results: The level of lesion regression was high, and 70 percent of the patients were reported to have a larger than 75 percent reduction. There was an improvement in functional outcomes and a decrease in pain and bleeding. Side effects were very mild (temporarily swelled (15%), ulcerated (7.5%)). The satisfaction of the patients was high, as 75 percent of the patients indicated that they were highly satisfied with the outcome.
Conclusion: The use of sclerotherapy is a safe and effective way of oral hemangioma treatment that has numerous functional and aesthetic outcomes alongside minimal complications.
References
2. Wiegand S, Dietz A, Wichmann G. Malignant Vascular Tumors of the Head and Neck—Which Type of Therapy Works Best?. Cancers. 2021 Dec 9;13(24):6201.
3. Do K, Kawana E, Shah S, Salinas J, Bigcas JL. Systematic Review: Effectiveness of Carbon Dioxide Lasers for Treatment of Adult Laryngeal Hemangioma. Journal of Otolaryngology-Head & Neck Surgery. 2025 Jan;54:19160216251314789.
4. ZHENG JW, ZHAO ZL, CHEN QM. Current evidence-based treatment of infantile hemangiomas. China Journal of Oral and Maxillofacial Surgery. 2022 Jan 20;20(1):7.
5. Julio CO, Vázquez L, Jhoan AR. Radiofrequency treatment of labial hemangioma. J Otolaryngol ENT Res. 2022;14(3):80-4.
6. Hajjaj A, van Overdam KA, Gishti O, Ramdas WD, Kiliç E. Efficacy and safety of current treatment options for peripheral retinal haemangioblastomas: a systematic review. Acta ophthalmologica. 2022 Feb;100(1):e38-46.
7. Zhou J, Qiu T, Zhang Z, Lan Y, Huo R, Xiang B, Chen S, Qiu L, Xia C, Xu X, Li J. Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma. International Journal of Cancer. 2025 May 15;156(10):1986-94.
8. Viteri VM, Aranibar L. 52192 Oral atenolol compared with oral propranolol for infantile hemangioma: a Friendly Summary of the Body of Evidence (FRISBEE). Journal of the American Academy of Dermatology. 2024 June 1;91(3):AB270.
9. Dahan E, Abou Jaoude L. Infantile hemangiomas: a review of current treatment options. Pediatric Annals. 2023 May 1;52(5):e192-7.
10. Maniaci A, La Via L, Lavalle S, Lentini M, Pavone P, Iannella G, Cocuzza S. Presentation, Radiologic Features, and Treatment Options of Congenital Tongue Tumors: A Comprehensive Review. Annali Italiani di Chirurgia. 2024 July 19;95(4):481-96.
11. Rivka Friedland MD, Michal Neumark MD, Jacob Mashiah MD, Liat Samuelov MD, Ayelet Shani-Adir MD, Hiba Zaaroura MD, Amir Horev MD, Shoshana Greenberger M. Guidelines for the Treatment of Infantile Hemangiomas: A Position Paper from the Israeli Association of Dermatology and Venereology.
12. Alhazmi AM, Basendwh MA, Aman AA, Dajam M, Aljuhani TS. The role of systemic and topical beta-blockers in dermatology: a systematic review. Dermatology and Therapy. 2023 Jan;13(1):29-49.
13. Hashemi DA, Tao J, Wang JV, Geronemus RG. The 595‐nm Wavelength Pulsed Dye Laser for Pediatric Port‐Wine Birthmarks and Infantile Hemangiomas: A Systematic Review. Lasers in Surgery and Medicine. 2025 Jan;57(1):27-36.
14. Lin Q, Hai Y, Chen S, Feng N, Mo Z, Wei Y, Luo Q, Huang X, Fan L, Chen J, Xiang W. Mediastinal and subglottic hemangioma in an infant: a case report and literature review. Journal of International Medical Research. 2021 Aug;49(8):03000605211039803.
15. Lilje D, Wiesmann M, Hasan D, Riabikin A, Ridwan H, Hölzle F, Nikoubashman O. Interventional therapy of extracranial arteriovenous malformations of the head and neck—A systematic review. PloS one. 2022 Jul 15;17(7):e0268809.
16. Akers AL, Albanese J, Alcazar-Felix RJ, Salman RA, Awad IA, Connolly ES, Danehy A, Flemming KD, Gordon E, Hage S, Kim H. Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord: Consensus Recommendations Based on a Systematic Literature Review by the Alliance to Cure Cavernous Malformation Clinical Advisory Board Experts Panel. Neurosurgery. 2022 May 17:10-227.
17. Avais LS, Pacheco EC, Gomes LP, Baldani MH, Martins CM, Waldman EA, Gonzalez JP, Steen TY, Borges PK. Oral Manifestations in the Post COVID‐19 Condition: A Systematic Review With Meta‐Analysis. Reviews in Medical Virology. 2025 Jul;35(4):e70057.
18. Saeg F, Orazi R, Bowers GM, Janis JE. Evidence-based nutritional interventions in wound care. Plastic and reconstructive surgery. 2021 Jul 1;148(1):226-38.
19. Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, Glastonbury C, Kaufman M, Lamarre E, Lau HY, Licitra L. Management of salivary gland malignancy: ASCO guideline. Journal of Clinical Oncology. 2021 Jun 10;39(17):1909-41.